Montmed announced the launch of the SiteSmart® GLP-1 Pack, a pen needle format specifically designed for patients using once-weekly GLP-1 therapies. Developed in response to the rapid growth of medications [...]
Montmed announced that it has resumed direct distribution and commercialization of SiteSmart®, regaining full control of the product's strategic direction and market development activities. The transition strengthens Montmed's ability to [...]
Montmed, Inc., a company dedicated to bridging the gap between science and behavior in diabetes care to deliver better outcomes while reducing the cognitive burden associated with living with diabetes, [...]
Results from a randomized controlled trial evaluating SiteSmart® were published in Diabetes Therapy, providing independent clinical validation of Montmed's patented injection site rotation solution. The study demonstrated that the sole [...]
Results of a randomized controlled trial demonstrating the clinical value of utilizing retail pharmacists to improve injection site rotation with the novel SiteSmartTM pen needle system are presented in the [...]
Montmed Inc. Announces Issuance of US Patent for SiteSmart™ Pen Needles MONTREAL, January 10, 2020 /CNW Telbec/ - Montmed, Inc., a company dedicated to enabling people with diabetes to [...]